Bafna Pharmaceuticals board to consider financial results

09 Aug 2012 Evaluate
Bafna Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 14, 2012 to consider the un-audited financial results for the quarter ending June 30, 2012, and the allotment of shares pursuant to conversion of warrants into shares, warrants allotted on March 17, 2011.

Further, the board will fix date, time and venue of 17th annual general meeting of the members of the company and will approve book closure for the purpose of annual general meeting.

The above information is a part of company's filings submitted to BSE.

Bafna Pharma Share Price

94.77 -4.98 (-4.99%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.